tiprankstipranks
Advertisement
Advertisement
Ultragenyx price target raised to $103 from $96 at Cantor Fitzgerald
PremiumThe FlyUltragenyx price target raised to $103 from $96 at Cantor Fitzgerald
4d ago
Ultragenyx price target raised to $83 from $81 at Canaccord
Premium
The Fly
Ultragenyx price target raised to $83 from $81 at Canaccord
5d ago
Ultragenyx: FDA-Backed Gene Therapy Momentum and Late-Stage Pipeline Support Reiterated Buy Rating and Unchanged $50 Price Target
Premium
Ratings
Ultragenyx: FDA-Backed Gene Therapy Momentum and Late-Stage Pipeline Support Reiterated Buy Rating and Unchanged $50 Price Target
5d ago
Ultragenyx Wins FDA Accelerated Approval for GENGLYCOS
PremiumCompany AnnouncementsUltragenyx Wins FDA Accelerated Approval for GENGLYCOS
5d ago
Ultragenyx announces FDA accelerated approval of Genglycos
Premium
The Fly
Ultragenyx announces FDA accelerated approval of Genglycos
5d ago
Ultragenyx Settles DOJOLVI Patent Dispute with Esjay
Premium
Company Announcements
Ultragenyx Settles DOJOLVI Patent Dispute with Esjay
13d ago
Ultragenyx: Strong Q2 Beat, Clear Path to FY27 Profitability and Catalyst-Rich 2H26 Support Buy Rating
PremiumRatingsUltragenyx: Strong Q2 Beat, Clear Path to FY27 Profitability and Catalyst-Rich 2H26 Support Buy Rating
20d ago
Closing Bell Movers: SpaceX slips after first quarterly report as public company
Premium
The Fly
Closing Bell Movers: SpaceX slips after first quarterly report as public company
20d ago
Ultragenyx reports Q2 EPS ($0.90), consensus ($1.24)
Premium
The Fly
Ultragenyx reports Q2 EPS ($0.90), consensus ($1.24)
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100